Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

FranceBack to France

Clinical trials in Isère

1 clinical trial in Isère, France. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Isère at a glance
1
clinical trial
  • Recruiting now0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

1 trial in Isère

Open in trial search

Arteriosclerosis

Not yet recruiting
Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.

Other cities in France

The busiest research cities in the country

All 379 cities in France

Clinical research in Isère

What the registry says about research in the country

01 Isère
Cardiovascular and metabolic research
Clinical trial activity in Isère is centered on Cardiovascular Diseases and Nutritional and Metabolic Diseases, with studies focusing on both heart health and blood sugar-related conditions. Research in Atherosclerotic Cardiovascular Disease Studies involving Elevated Lp(a) Trials in Diabetes Mellitus, Type 1 These trials are mainly designed to test new treatment approaches and better understand how to reduce disease risk and protect long-term health.
Type 1 diabetes and beta-cell preservation
One active area of research in Isère is Diabetes Mellitus, Type 1, with a clear focus on preserving the body’s own insulin-producing cell function after diagnosis. Preserving β-cell function Supporting early intervention in newly diagnosed patients Evaluating treatment effectiveness for better diabetes control This work aims to see whether a new therapy can help maintain natural insulin production in children, teenagers, and adults with recent-onset disease.
Cardiovascular risk reduction
Another trial in the region is centered on Atherosclerotic Cardiovascular Disease, exploring ways to lower the chance of serious heart-related events in adults with elevated Lipoprotein(a). Reducing major cardiovascular event risk Studying Elevated Lp(a) as a key risk factor Testing a new strategy for event prevention The research is aimed at improving prevention for people with higher inherited cardiovascular risk.
Back to FranceAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.